Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$2.01 - $7.19 $248,464 - $888,784
-123,614 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$6.24 - $14.04 $1.98 Million - $4.46 Million
-317,562 Reduced 71.98%
123,614 $771,000
Q3 2021

Nov 09, 2021

BUY
$16.0 - $22.51 $7.06 Million - $9.93 Million
441,176 New
441,176 $8.32 Million

Others Institutions Holding OMGA

About Omega Therapeutics, Inc.


  • Ticker OMGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,853,400
  • Market Cap $6.22M
  • Description
  • Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...
More about OMGA
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.